Healthcare Industry Reports

Reports > Healthcare > Selected Report

Global Targeted RNA Sequencing Market Report for Forcast Period 2017 to 2022

Single User: $2195
Multiple User: $3195
Enterprise User: $4195


Report Summary:

Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing the ability to detect both known and novel gene fusion partners in many sample types.

Scope of the Report:
This report focuses on the Targeted RNA Sequencing in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Thermo Fisher
Illumina
Roche Holdings
BGI
Eurofins
LabCorp
Berry Genomics
Macrogen
GENEWIZ

Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Type 1
Type 2

Market Segment by Applications, can be divided into
Research Institutes
Hospitals & Clinics
Biotechnology Company
Others

There are 15 Chapters to deeply display the global Targeted RNA Sequencing market.

Chapter 1, to describe Targeted RNA Sequencing Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Targeted RNA Sequencing, with sales, revenue, and price of Targeted RNA Sequencing, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Targeted RNA Sequencing, for each region, from 2012 to 2017;

Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 12, Targeted RNA Sequencing market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 13, 14 and 15, to describe Targeted RNA Sequencing sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents / Index:

Table of Contents

1 Market Overview
1.1 Targeted RNA Sequencing Introduction
1.2 Market Analysis by Type
1.2.1 Type 1
1.2.2 Type 2
1.3 Market Analysis by Applications
1.3.1 Research Institutes
1.3.2 Hospitals & Clinics
1.3.3 Biotechnology Company
1.3.4 Others
1.4 Market Analysis by Regions
1.4.1 North America (USA, Canada and Mexico)
1.4.1.1 USA Market States and Outlook (2012-2022)
1.4.1.2 Canada Market States and Outlook (2012-2022)
1.4.1.3 Mexico Market States and Outlook (2012-2022)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2012-2022)
1.4.2.2 France Market States and Outlook (2012-2022)
1.4.2.3 UK Market States and Outlook (2012-2022)
1.4.2.4 Russia Market States and Outlook (2012-2022)
1.4.2.5 Italy Market States and Outlook (2012-2022)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2012-2022)
1.4.3.2 Japan Market States and Outlook (2012-2022)
1.4.3.3 Korea Market States and Outlook (2012-2022)
1.4.3.4 India Market States and Outlook (2012-2022)
1.4.3.5 Southeast Asia Market States and Outlook (2012-2022)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2012-2022)
1.4.4.2 Egypt Market States and Outlook (2012-2022)
1.4.4.3 Saudi Arabia Market States and Outlook (2012-2022)
1.4.4.4 South Africa Market States and Outlook (2012-2022)
1.4.4.5 Nigeria Market States and Outlook (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Thermo Fisher
2.1.1 Business Overview
2.1.2 Targeted RNA Sequencing Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Thermo Fisher Targeted RNA Sequencing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Illumina
2.2.1 Business Overview
2.2.2 Targeted RNA Sequencing Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Illumina Targeted RNA Sequencing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Roche Holdings
2.3.1 Business Overview
2.3.2 Targeted RNA Sequencing Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Roche Holdings Targeted RNA Sequencing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 BGI
2.4.1 Business Overview
2.4.2 Targeted RNA Sequencing Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 BGI Targeted RNA Sequencing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Eurofins
2.5.1 Business Overview
2.5.2 Targeted RNA Sequencing Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Eurofins Targeted RNA Sequencing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 LabCorp
2.6.1 Business Overview
2.6.2 Targeted RNA Sequencing Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 LabCorp Targeted RNA Sequencing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Berry Genomics
2.7.1 Business Overview
2.7.2 Targeted RNA Sequencing Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Berry Genomics Targeted RNA Sequencing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Macrogen
2.8.1 Business Overview
2.8.2 Targeted RNA Sequencing Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 Macrogen Targeted RNA Sequencing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 GENEWIZ
2.9.1 Business Overview
2.9.2 Targeted RNA Sequencing Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 GENEWIZ Targeted RNA Sequencing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Targeted RNA Sequencing Market Competition, by Manufacturer
3.1 Global Targeted RNA Sequencing Sales and Market Share by Manufacturer
3.2 Global Targeted RNA Sequencing Revenue and Market Share by Manufacturer
3.3 Market Concentration Rate
3.3.1 Top 3 Targeted RNA Sequencing Manufacturer Market Share
3.3.2 Top 6 Targeted RNA Sequencing Manufacturer Market Share
3.4 Market Competition Trend
4 Global Targeted RNA Sequencing Market Analysis by Regions
4.1 Global Targeted RNA Sequencing Sales, Revenue and Market Share by Regions
4.1.1 Global Targeted RNA Sequencing Sales by Regions (2012-2017)
4.1.2 Global Targeted RNA Sequencing Revenue by Regions (2012-2017)
4.2 North America Targeted RNA Sequencing Sales and Growth (2012-2017)
4.3 Europe Targeted RNA Sequencing Sales and Growth (2012-2017)
4.4 Asia-Pacific Targeted RNA Sequencing Sales and Growth (2012-2017)
4.5 South America Targeted RNA Sequencing Sales and Growth (2012-2017)
4.6 Middle East and Africa Targeted RNA Sequencing Sales and Growth (2012-2017)
5 North America Targeted RNA Sequencing by Countries
5.1 North America Targeted RNA Sequencing Sales, Revenue and Market Share by Countries
5.1.1 North America Targeted RNA Sequencing Sales by Countries (2012-2017)
5.1.2 North America Targeted RNA Sequencing Revenue by Countries (2012-2017)
5.2 USA Targeted RNA Sequencing Sales and Growth (2012-2017)
5.3 Canada Targeted RNA Sequencing Sales and Growth (2012-2017)
5.4 Mexico Targeted RNA Sequencing Sales and Growth (2012-2017)
6 Europe Targeted RNA Sequencing by Countries
6.1 Europe Targeted RNA Sequencing Sales, Revenue and Market Share by Countries
6.1.1 Europe Targeted RNA Sequencing Sales by Countries (2012-2017)
6.1.2 Europe Targeted RNA Sequencing Revenue by Countries (2012-2017)
6.2 Germany Targeted RNA Sequencing Sales and Growth (2012-2017)
6.3 UK Targeted RNA Sequencing Sales and Growth (2012-2017)
6.4 France Targeted RNA Sequencing Sales and Growth (2012-2017)
6.5 Russia Targeted RNA Sequencing Sales and Growth (2012-2017)
6.6 Italy Targeted RNA Sequencing Sales and Growth (2012-2017)
7 Asia-Pacific Targeted RNA Sequencing by Countries
7.1 Asia-Pacific Targeted RNA Sequencing Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Targeted RNA Sequencing Sales by Countries (2012-2017)
7.1.2 Asia-Pacific Targeted RNA Sequencing Revenue by Countries (2012-2017)
7.2 China Targeted RNA Sequencing Sales and Growth (2012-2017)
7.3 Japan Targeted RNA Sequencing Sales and Growth (2012-2017)
7.4 Korea Targeted RNA Sequencing Sales and Growth (2012-2017)
7.5 India Targeted RNA Sequencing Sales and Growth (2012-2017)
7.6 Southeast Asia Targeted RNA Sequencing Sales and Growth (2012-2017)
8 South America Targeted RNA Sequencing by Countries
8.1 South America Targeted RNA Sequencing Sales, Revenue and Market Share by Countries
8.1.1 South America Targeted RNA Sequencing Sales by Countries (2012-2017)
8.1.2 South America Targeted RNA Sequencing Revenue by Countries (2012-2017)
8.2 Brazil Targeted RNA Sequencing Sales and Growth (2012-2017)
8.3 Argentina Targeted RNA Sequencing Sales and Growth (2012-2017)
8.4 Columbia Targeted RNA Sequencing Sales and Growth (2012-2017)
9 Middle East and Africa Targeted RNA Sequencing by Countries
9.1 Middle East and Africa Targeted RNA Sequencing Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Targeted RNA Sequencing Sales by Countries (2012-2017)
9.1.2 Middle East and Africa Targeted RNA Sequencing Revenue by Countries (2012-2017)
9.2 Saudi Arabia Targeted RNA Sequencing Sales and Growth (2012-2017)
9.3 UAE Targeted RNA Sequencing Sales and Growth (2012-2017)
9.4 Egypt Targeted RNA Sequencing Sales and Growth (2012-2017)
9.5 Nigeria Targeted RNA Sequencing Sales and Growth (2012-2017)
9.6 South Africa Targeted RNA Sequencing Sales and Growth (2012-2017)
10 Global Targeted RNA Sequencing Market Segment by Type
10.1 Global Targeted RNA Sequencing Sales, Revenue and Market Share by Type (2012-2017)
10.1.1 Global Targeted RNA Sequencing Sales and Market Share by Type (2012-2017)
10.1.2 Global Targeted RNA Sequencing Revenue and Market Share by Type (2012-2017)
10.2 Type 1 Sales Growth and Price
10.2.1 Global Type 1 Sales Growth (2012-2017)
10.2.2 Global Type 1 Price (2012-2017)
10.3 Type 2 Sales Growth and Price
10.3.1 Global Type 2 Sales Growth (2012-2017)
10.3.2 Global Type 2 Price (2012-2017)
11 Global Targeted RNA Sequencing Market Segment by Application
11.1 Global Targeted RNA Sequencing Sales Market Share by Application (2012-2017)
11.2 Research Institutes Sales Growth (2012-2017)
11.3 Hospitals & Clinics Sales Growth (2012-2017)
11.4 Biotechnology Company Sales Growth (2012-2017)
11.5 Others Sales Growth (2012-2017)
12 Targeted RNA Sequencing Market Forecast (2017-2022)
12.1 Global Targeted RNA Sequencing Sales, Revenue and Growth Rate (2017-2022)
12.2 Targeted RNA Sequencing Market Forecast by Regions (2017-2022)
12.2.1 North America Targeted RNA Sequencing Market Forecast (2017-2022)
12.2.2 Europe Targeted RNA Sequencing Market Forecast (2017-2022)
12.2.3 Asia-Pacific Targeted RNA Sequencing Market Forecast (2017-2022)
12.2.4 South America Targeted RNA Sequencing Market Forecast (2017-2022)
12.2.5 Middle East and Africa Targeted RNA Sequencing Market Forecast (2017-2022)
12.3 Targeted RNA Sequencing Market Forecast by Type (2017-2022)
12.4 Targeted RNA Sequencing Market Forecast by Application (2017-2022)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source

Research Methodology

The market research report added recently to collection of Market Reports Company is based on detailed qualitative and quantitative analysis. The research report is a blend of both bottom up and top down research with the help of which quantitative aspects of the market are determined. Besides this various statistical models, projection techniques and sampling techniques are implemented for quantitative analysis.
The qualitative analysis includes through interactive study with all major industry participants across the industrial value chain. The analysis includes extensive interviews with raw material suppliers, experienced front line staff, directors, CEOs, distributors, major manufacturers, industry experts and end-users. Interaction are usually done with the help of primary interviews, surveys, and vendor briefings. All major factors that influence this market are studied in this research report. The market size for top level markets and sub-segments is normalized, and the impact of various macro and micro economic factors are analyzed during market forecast.

Secondary Research
Secondary sources play a vital role in collection of raw data. Various paid and open access data sources are referred for collection for secondary data. Some of the major secondary data sources referred include:

■ Press releases, annual reports, Non-Profit organizations
■ Industry associations, governmental agencies and customs data
■ Directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), etc.

Primary Research
In Primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Some of the major primary sources include:

■ Product manufacturers
■ Opinion leaders, industry experts and research institutions
■ Distributors, Dealer and Traders
■ Raw Materials suppliers and producers etc.

The data collected through secondary research is validated with the help of primary research respondents.

Data Models
Wherever no credible data sources are available, various data models are implemented which help to develop wide data sets.

Request a Sample of this Report

Please fill out the details requested below.
Our representative will contact you within 1 hour.


Name:


Email ID:


Name of Company:


Designation/Role:


Country:


Message:


Please Enter Captcha Below:

Report Details:



Report ID: 32862

Category: 11

Published date: 2017-09-18 02:55:21

Number of Pages: 115

Publisher Name: GIR (Global Info Research)

Over all Rating: 81 % (Average of Ratings provided by clients)